Trinity Biotech plc reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported sales was USD 13.43 million compared to USD 15.73 million a year ago. Net loss was USD 5.5 million compared to USD 10.08 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.75 USD | -3.85% | -4.37% | -18.41% |
1st Jan change | Capi. | |
---|---|---|
-18.41% | 16.52M | |
-9.59% | 7.67B | |
+1.80% | 5.41B | |
+8.69% | 4.62B | |
+0.02% | 4.57B | |
-51.89% | 3.22B | |
+6.42% | 2.59B | |
-13.71% | 2.05B | |
-8.29% | 1.79B | |
+1.67% | 1.76B |
- Stock Market
- Equities
- TRIB Stock
- News Trinity Biotech plc
- Trinity Biotech plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2023